Browse the evidence

There is a causal relationship between glucose-stimulated insulin secretion and body weight.

Practitioners should consider the role of insulin secretion in weight management strategies.

Fish oil increased adiponectin by 0.37 μg/mL (95% CI 0.07; 0.67, P = .02).

Incorporating fish oil supplements may help increase adiponectin levels, potentially improving insulin sensitivity.

Mean 24-h circulating leptin concentration decreased by -44 ± 3% (P < 0.001) after CR.

Caloric restriction significantly reduces leptin levels, which may affect energy expenditure.

A significant improvement was observed in eating behavior in the probiotic group compared to the placebo group.

Probiotic supplementation may help improve eating behaviors in this population.

Serum levels of oxytocin increased and NPY decreased significantly in the probiotic group compared to the placebo group.

Probiotics may positively influence appetite-regulating hormones in obese women with food addiction.

Betaine and choline concentrations were associated with greater insulin sensitivity.

Increased intake of betaine and choline may enhance insulin sensitivity, suggesting potential dietary recommendations.

Postexercise hormonal spikes may enhance intracellular signaling to favor muscle protein synthesis.

Practitioners should consider the timing of workouts to maximize hormonal responses that support muscle growth.

Acute postexercise hormonal secretions may be more critical to hypertrophic adaptations than chronic changes in resting hormonal concentrations.

Emphasizing acute hormonal responses in training programs may enhance muscle growth outcomes.

Exercise in the supplemented condition significantly elevated plasma estradiol by approximately 83% for 90 minutes.

Resistance exercise combined with androstenedione supplementation significantly increases estradiol levels.

Targeting amylin receptors improves weight control and may act additively with other treatments.

Combining treatments targeting amylin receptors may enhance obesity management strategies.

GLP-1 receptor agonists (semaglutide, liraglutide) significantly improve cardiovascular biomarkers—including hs-CRP, systolic blood pressure, and lipid profiles—independent of glycemic control.

GLP-1 medications like semaglutide do more than just help you lose weight; they directly improve your heart health markers. They significantly lower systemic inflammation (hs-CRP), improve blood vessel function, lower blood pressure, and improve lipid profiles. These benefits happen even if you don't have diabetes, proving the drug protects your blood vessels directly. You should be aware of the slightly increased risk of gallbladder issues due to rapid weight loss, so your doctor will monitor your baseline risk.

Menopause is associated with a substantial decrease in endogenous oestrogen concentrations and alterations in body weight, adipose tissue distribution, and energy expenditure, which can predispose women to the development of type 2 diabetes mellitus (T2DM).

Practitioners should be aware of the increased risk of T2DM in menopausal women due to hormonal changes.

Hormone Replacement Treatment (HRT) has a favourable effect on glucose homeostasis in women with T2DM.

HRT may be considered for managing glucose levels in menopausal women with T2DM.

Mean 11-hour GH concentrations increased in the caloric restriction plus exercise (CR + EX) and low-calorie diet (LCD) groups.

Incorporating exercise with caloric restriction may enhance GH levels.

Liquid meal replacements lead to modest reductions in systolic blood pressure of −4.97 mmHg (−7.32 to −2.62).

Using liquid meal replacements may contribute to lowering blood pressure in this population.

GLP1-RA treatment is associated with improvements in mental health-related quality of life compared with placebo (g = 0.15; P < .001).

GLP1-RAs may enhance mental health quality of life in this population.

Physiologically elevated acute testosterone levels are linked to hypertrophic adaptations in resistance training.

Emphasize the importance of testosterone in resistance training for muscle growth.

There are quantitative sex differences in the response to GLP-1 and its analogs.

Practitioners should consider sex differences when prescribing GLP-1 analogs.

Alterations in metabolism, hormonal status, explosive strength, and psychological aspects of eating were observed during precontest preparation; however, all of these variables recovered quickly postcompetition.

Practitioners should note that while metabolic and hormonal changes occur during preparation, they are reversible postcompetition.

The share of prescriptions for semaglutide (Wegovy) increased to 27.7% among advanced practice practitioners (APPs) by February 2024.

Practitioners should consider the growing preference for semaglutide in obesity treatment.

Weight loss correlated with a 36% increase in plasma adiponectin concentration.

Increased adiponectin levels may contribute to improved metabolic health following weight loss.

The odds of discontinuation of glucose-lowering medications at year 1 differed by bMVPA timing, with the afternoon group having the highest odds (odds ratio 2.13).

Understanding the timing of physical activity may help in managing medication strategies for diabetes patients.

Tirzepatide resulted in significant decreases in systolic blood pressure of median -4.20 mmHg for 5 mg, -5.34 mmHg for 10 mg, and -5.77 mmHg for 15 mg.

Tirzepatide may be an effective treatment for reducing systolic blood pressure in patients.

Tirzepatide treatment resulted in significant decreases in total cholesterol levels: median -3.76% for 5 mg, -4.63% for 10 mg, and -5.93% for 15 mg.

Tirzepatide may help in managing cholesterol levels in patients.